| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/09/2004 | EP1424973A1 Disposal system for transdermal dosage form |
| 06/09/2004 | EP1424957A2 Microfabricated nanopore device for sustained release of therapeutic agent |
| 06/09/2004 | EP1424907A1 Oil composition |
| 06/09/2004 | EP1424898A1 Treatment of cancers by inhalation of stable platinum-containing formulations |
| 06/09/2004 | EP1424896A1 Method for expression of small rna molecules within a cell |
| 06/09/2004 | EP1424895A2 Method for expression of small antiviral rna molecules within a cell |
| 06/09/2004 | EP1424894A2 Inhibition of pathological angiogenesis in vivo |
| 06/09/2004 | EP1424889A2 Method for treating lung cancers |
| 06/09/2004 | EP1337535B1 Benzodiazepine derivatives as gaba a receptor modulators |
| 06/09/2004 | EP1299380B1 Indole derivatives useful for the treatment of cns disorders |
| 06/09/2004 | EP1286998B1 Oxazolidinone derivatives with antibiotic activity |
| 06/09/2004 | EP1276742B1 Process for the preparation of pyrazolopyridine derivatives |
| 06/09/2004 | EP1272148A4 Compositions for metabolic protection and repair of lips |
| 06/09/2004 | EP1246824B1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof |
| 06/09/2004 | EP1240137B1 Method for making 24(s)-hydroxyvitamin d 2 |
| 06/09/2004 | EP1235797B1 Aralkyl-1,2-diamines having calcimimetic activity and preparation mode |
| 06/09/2004 | EP1212323B1 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 06/09/2004 | EP1202966B1 Piperidine alcohols |
| 06/09/2004 | EP1196412B1 Nitrogen containing heterobicycles as factor xa inhibitors |
| 06/09/2004 | EP1196176B1 Use of beta-napthoquinone derivatives for the manufacture of a medicament having an inhibiting effect on the release of glutamate by the brain |
| 06/09/2004 | EP1180102B1 Mutual prodrugs of amlodipine and atorvastatin |
| 06/09/2004 | EP1173436B1 Thiazolidinedione derivative and its use as antidiabetic |
| 06/09/2004 | EP1171441B1 Morphinoid compounds |
| 06/09/2004 | EP1159267B1 N-substituted indolines as estrogenic agents |
| 06/09/2004 | EP1148875B1 Methods and compositions to enhance white blood cell count |
| 06/09/2004 | EP1143937B1 Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations |
| 06/09/2004 | EP1100795B1 Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effect |
| 06/09/2004 | EP1098897B1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 06/09/2004 | EP1082084B1 Anhydrous aerosol hairspray compositions containing silicone grafted copolymers |
| 06/09/2004 | EP1043978B1 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
| 06/09/2004 | EP1043310B1 Biphenylamidine derivatives |
| 06/09/2004 | EP1032263B1 Surfactant-based antimicrobial compositions and methods for using same |
| 06/09/2004 | EP1019364B1 Inhibitors of protein tyrosine phosphatase |
| 06/09/2004 | EP1007504B1 Sterilized 5-aminolevulinic acid |
| 06/09/2004 | EP1007043B1 Method for treatment of cns-involved lysosomal storage diseases |
| 06/09/2004 | EP1005339A4 Carotenoid formulation |
| 06/09/2004 | EP1000039B1 Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors |
| 06/09/2004 | EP0980366B1 Antithrombotic agents |
| 06/09/2004 | EP0975364B1 Allergen formulation |
| 06/09/2004 | EP0941737B1 Apoptosis inducers |
| 06/09/2004 | EP0892786B1 New carboxylic acid derivatives, their production and use |
| 06/09/2004 | EP0787494B1 Use of rifamycin derivatives for the manufacture of a medicament for the treatment of diseases caused by infections of helicobacter pylori |
| 06/09/2004 | EP0753053B1 ALPHAVIRUS cDNA VECTORS |
| 06/09/2004 | EP0748225B1 PHARMACEUTICALLY ACCEPTABLE DNase FORMULATION |
| 06/09/2004 | DE3910170B4 Zusammensetzung zur Bakterien-Desorption Composition for bacteria-desorption |
| 06/09/2004 | DE20220903U1 Rapidly acting composition used for treating pain, especially joint pain, comprises salicylic acid, aryl or heteroaryl-substituted carboxylic acid and colchicine or their derivatives |
| 06/09/2004 | DE20220902U1 Neuer Filmüberzug New film coating |
| 06/09/2004 | DE19534745B4 Verfahren zur Herstellung von 6-Hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]benzo[b]thiophen Thiophene process for the preparation of 6-hydroxy-2- (4-hydroxyphenyl) -3- [4- (2-piperidinoethoxy) benzoyl] benzo [b] |
| 06/09/2004 | DE10320603A1 Verfahren zum Testen der Aktivität einer möglichen wirksamen Substanz, die die enzymatische Aktivität der Phospholipase A2 hemmen kann A method for testing the activity of a possible active substance which inhibit the enzymatic activity of phospholipase A2 can |
| 06/09/2004 | DE10256184A1 Reducing hepatotoxicity of microsomal triglyceride transfer protein inhibitors, used e.g. in treatment of hyperlipemia, atherosclerosis or diabetes, by co-administration with fibrate |
| 06/09/2004 | DE10255415A1 Dermale Applikation von Flupirtin Dermal application of flupirtine |
| 06/09/2004 | DE10255387A1 Neue Tiotropium-haltige Pulverformulierung für die Inhalation New tiotropium containing powder formulation for inhalation |
| 06/09/2004 | DE10254584A1 Verwendung von mittelkettigen Triglyceriden (MCT) zur ernährungsphysiologischen Optimierung des Fettsäurenspektrums in einem diätetischen Lebensmittel für Diabetiker The use of medium chain triglycerides (MCT) to optimize the nutritional fatty acids spectrum in a dietetic foods for diabetics |
| 06/09/2004 | DE10142667B4 C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel C2-substituted indan-1-ols and their derivatives, and their use as medicaments |
| 06/09/2004 | DE10142661B4 Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel Multiple-substituted indan-1-ol-systems and their use as medicaments |
| 06/09/2004 | CN1503843A Vaccination against host cell-associated herpesviruses |
| 06/09/2004 | CN1503816A Agent for the prevention and treatment of sexually transmitted diseases-1 |
| 06/09/2004 | CN1503802A Sulfate of cephem compound |
| 06/09/2004 | CN1503801A Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino [2,3-f] quinoxaline |
| 06/09/2004 | CN1503800A antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7h-[1,4] dioxino [2,3-3] indole |
| 06/09/2004 | CN1503799A Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza cyclopenta [A] naphthalene |
| 06/09/2004 | CN1503798A Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused- [1,4]-derivatives of oxaheterocycle-fused-[1,4]-benzodioxans |
| 06/09/2004 | CN1503797A Pyridopyrimidine or naphthyridine derivative |
| 06/09/2004 | CN1503796A Polymorphic and other crystalling forms of cis-ftc |
| 06/09/2004 | CN1503794A Inhiitors of cyclin dependent kinases as anti-cancer agent |
| 06/09/2004 | CN1503793A N-substituted nonabyl-heterocyclic nmda/nrzb antagonists |
| 06/09/2004 | CN1503792A Phthalazinones derivatives useful as pde 4/7 inhibtors |
| 06/09/2004 | CN1503791A Process for purifying 6-methoxy omeprazole |
| 06/09/2004 | CN1503790A Heterocyclic sulfonamide inhibitors of beta amyloid production |
| 06/09/2004 | CN1503788A Novel azoles having an insecticidal action |
| 06/09/2004 | CN1503787A Novel compounds |
| 06/09/2004 | CN1503786A Large conductance calcium-activated k channel opener |
| 06/09/2004 | CN1503784A 2-lminopyrrolidine derivatives |
| 06/09/2004 | CN1503782A Certain salts of discodermolide acid pharmaceutical compositions containing them and their use in treating tumors |
| 06/09/2004 | CN1503781A Process for the preparatino of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 06/09/2004 | CN1503684A Use of nk-1 receptor antagonists against benign prostatic hyperplasia |
| 06/09/2004 | CN1503679A Anticancer drug-chitosan complex forming self-aggregates and preparation method thereof |
| 06/09/2004 | CN1503676A Method for treating gout and reducing serum uric a cid |
| 06/09/2004 | CN1503675A Telithromycin suspension with a masked taste |
| 06/09/2004 | CN1503674A Medicines anjd medicinal kits |
| 06/09/2004 | CN1503673A antiinflammation agents |
| 06/09/2004 | CN1503672A 6-substituted pyrido-pyrimidines |
| 06/09/2004 | CN1503671A Agent for topical ophthalmic treatment of ocular inflammatory diseases |
| 06/09/2004 | CN1503670A Gastric acid secretion inhibiting composition |
| 06/09/2004 | CN1503669A Antiviral agents and methods of treating viral infections |
| 06/09/2004 | CN1503668A Use of rare earth compounds for the prevention of kidney stone disease |
| 06/09/2004 | CN1503667A Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 06/09/2004 | CN1503666A Carbamate compounds for use in preventing or treating bipolar disorder |
| 06/09/2004 | CN1503665A Carbamate compounds for sue in preventing or treating anxiety disorders |
| 06/09/2004 | CN1503664A Colloidal suspension of nanoparticles based on am amphiphilic copolymer |
| 06/09/2004 | CN1503663A Film coating |
| 06/09/2004 | CN1503662A Pharmaceutical preparation |
| 06/09/2004 | CN1503659A Skin care compositions containing sugar amine |
| 06/09/2004 | CN1503658A Systems for delivering a cosmetic and/or therapeutic active to oral surfaces using an integral carrier |
| 06/09/2004 | CN1503655A Sugar intake promoters |
| 06/09/2004 | CN1503632A Nutritional composition for immune condition |
| 06/09/2004 | CN1502702A Trehalose-releasing enzyme, and its preparation and use |
| 06/09/2004 | CN1502621A Crystalline n-acetyl neuraminic acid derivatives pharmaceutical compns contg. Them |
| 06/09/2004 | CN1502617A Aromatic amides, preparation method and application as medicines |
| 06/09/2004 | CN1502616A Method for the preparation of citalopram |